Atum Signs Patent Licensing Agreement With Thermo Fisher Scientific
NEWARK, Calif.--(BUSINESS WIRE)-- ATUM (formerly DNA TwoPointO, Inc.) announced today that the company has signed a patent licensing agreement that gives Thermo Fisher Scientific access to certain systems and methods for gene design as described in United States Patent No. 7,805,202.
"Most people think visually, so seeing a graphic representation of a sequence is very helpful in the design process,” said Alan Villalobos, ATUM's Vice President of Synthetic Biology and an inventor of the method. “This patent family is directed to representing sequence elements as icons, and features a drag and drop function that is crucial for avoiding errors that creep in during cut-and-paste operations, when one nucleotide missed can destroy the function of the entire construct. We are delighted that Thermo Fisher is utilizing these features."
About ATUM
ATUM, formerly DNA2.0, offers an integrated pipeline of tools including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering and production. ATUM exploits the dependence of biological activity on well-designed sequences. ATUM’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. By collaborating with our clients, ATUM accelerates breakthroughs and moves research further faster. The company is privately held and is headquartered in Newark, California. For more information, please visit https://www.atum.bio.
About Gene Designer 2.0
Gene Designer 2.0 software, introduced by ATUM in 2005, captures the entire gene design process in one efficient application, using a range of design tools purposely built for the task:
• Intelligent algorithms for in silico cloning, codon optimization, back translation and primer design.
• Graphically rich molecular view to display, annotate and edit constructs.
• Customizable database to store, manage, and track genetic element, genes and constructs.
• Drag-and-drop interface for moving sequence elements within or between constructs.
Contacts
Atum Press Contact:
Lisa Lilienthal, 404-661-3679
lisa@iconatl.com
"Most people think visually, so seeing a graphic representation of a sequence is very helpful in the design process,” said Alan Villalobos, ATUM's Vice President of Synthetic Biology and an inventor of the method. “This patent family is directed to representing sequence elements as icons, and features a drag and drop function that is crucial for avoiding errors that creep in during cut-and-paste operations, when one nucleotide missed can destroy the function of the entire construct. We are delighted that Thermo Fisher is utilizing these features."
About ATUM
ATUM, formerly DNA2.0, offers an integrated pipeline of tools including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering and production. ATUM exploits the dependence of biological activity on well-designed sequences. ATUM’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. By collaborating with our clients, ATUM accelerates breakthroughs and moves research further faster. The company is privately held and is headquartered in Newark, California. For more information, please visit https://www.atum.bio.
About Gene Designer 2.0
Gene Designer 2.0 software, introduced by ATUM in 2005, captures the entire gene design process in one efficient application, using a range of design tools purposely built for the task:
• Intelligent algorithms for in silico cloning, codon optimization, back translation and primer design.
• Graphically rich molecular view to display, annotate and edit constructs.
• Customizable database to store, manage, and track genetic element, genes and constructs.
• Drag-and-drop interface for moving sequence elements within or between constructs.
Contacts
Atum Press Contact:
Lisa Lilienthal, 404-661-3679
lisa@iconatl.com